Jason Frishman is the founder and CEO of Netcapital. Jason has been mentoring, advising, and investing in early stage companies to help them raise their first capital for over three years. He founded Netcapital to reduce the systemic inefficiencies he saw in the way early stage companies access capital through his experience as a coach and mentor.

Jason holds advisory positions with leading organizations in the financial technology ecosystem, and has conducted speaking engagements as an external expert with Morgan Stanley, University of Michigan, YPO, and others.

Jason has a background in the life sciences and has previously conducted research in medical oncology at the Dana Farber Cancer Institute and cognitive neuroscience at the University of Miami, where he graduated summa cum laude with a B.S. in Neuroscience. Prior to shifting his attention to the world of private early stage financings, he co-authored a paper published in the medical oncology periodical Cancer Cell.